S. Cholerton
- Pharmacology top 0.2%
- Molecular Biology top 10%
- Oncology top 10%
- Cancer Research top 10%
- Physiology top 10%
- Co-authors
- Jeffrey R. IdleAnn K. DalyMelissa J. ArmstrongAM BreckenridgeD. Nicholas BatemanBP HaynesW. Larry GregoryPedro M. Fernández‐Salguero
- Topics
- Pharmacogenetics and Drug Metabolism (17 papers)Glutathione Transferases and Polymorphisms (7 papers)Vitamin K Research Studies (6 papers)
- Partner nations
- United KingdomTürkiyeJordan
In The Last Decade
S. Cholerton
40 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 104
- Pharmacology 937
- Molecular Biology 716
- Oncology 370
- Cancer Research 239
- Physiology 198
Countries citing papers authored by S. Cholerton
This map shows the geographic impact of S. Cholerton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Cholerton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Cholerton more than expected).
Fields of papers citing papers by S. Cholerton
This network shows the impact of papers produced by S. Cholerton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Cholerton. The network helps show where S. Cholerton may publish in the future.
Co-authorship network of co-authors of S. Cholerton
This figure shows the co-authorship network connecting the top 25 collaborators of S. Cholerton. A scholar is included among the top collaborators of S. Cholerton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Cholerton. S. Cholerton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 11 | |
| 2 | 34 | |
| 3 | 20 | |
| 4 | 6 | |
| 5 | 37 | |
| 6 | 60 | |
| 7 | 83 | |
| 8 | 29 | |
| 9 | 54 | |
| 10 | 4 | |
| 11 | 31 | |
| 12 | 105 | |
| 13 | 10 | |
| 14 | 78 | |
| 15 | 138 | |
| 16 | 211 | |
| 17 | 71 | |
| 18 | The preeminence of nicotine n oxidation and its diminution after carbimazole administration | 7 |
| 19 | 4 | |
| 20 | 49 |
About S. Cholerton
S. Cholerton is a scholar working on Pharmacology, Biochemistry and Pharmaceutical Science, having authored 40 papers that have together received 2.1k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (17 papers), Glutathione Transferases and Polymorphisms (7 papers) and Vitamin K Research Studies (6 papers). The work is most often cited by research in Pharmacology (937 citations), Biochemistry (117 citations) and Cancer Research (239 citations). S. Cholerton has collaborated with scholars based in United Kingdom, Türkiye and Jordan. Frequent co-authors include Jeffrey R. Idle, Ann K. Daly, Melissa J. Armstrong, AM Breckenridge, D. Nicholas Bateman, BP Haynes, W. Larry Gregory, Pedro M. Fernández‐Salguero, Arja Rautio and Olavi Pelkonen. Their work appears in journals such as The Lancet, Environmental Health Perspectives and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.